About Polyclinique de Blois; Chimiotherapie Ambulatoire
"Certifiée A sur la V 2014 en décembre 2018, la Polyclinique de Blois développe sa politique qualité autour de 3 axes majeurs : hygiène, qualité de l’accueil et sécurité des soins. Sa mission : être au plus près du patient pour lui apporter un soin de qualité avec une technologie à la pointe. A la pointe du développement, la Polyclinique de Blois investit régulièrement : - acquisition du robot DA Vinci, (outils technologique associant qualité et sécurité des soins et attractivité pour les chirurgiens) . - ouverture d’un plateau technique dédié à l’ophtalmologie - création d’une salle nature : un nouvel espace proposé aux mamans pour vivre autrement son accouchement alliant bien être, sérénité et sécurité."
Clinical Trials at Polyclinique de Blois; Chimiotherapie Ambulatoire
During the past decade, Polyclinique de Blois; Chimiotherapie Ambulatoire conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Polyclinique de Blois; Chimiotherapie Ambulatoire
According to Clinical.Site data, the most researched conditions in "Polyclinique de Blois; Chimiotherapie Ambulatoire" are
"Colorectal Cancer" (2 trials), "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Polyclinique de Blois; Chimiotherapie Ambulatoire" in a lesser frequency.
Clinical Trials Intervention Types at Polyclinique de Blois; Chimiotherapie Ambulatoire
Most popular intervention types in "Polyclinique de Blois; Chimiotherapie Ambulatoire" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Trastuzumab" (2 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Nab-paclitaxel" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Polyclinique de Blois; Chimiotherapie Ambulatoire
The vast majority of trials in "Polyclinique de Blois; Chimiotherapie Ambulatoire" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Polyclinique de Blois; Chimiotherapie Ambulatoire
Currently, there are NaN active trials in "Polyclinique de Blois; Chimiotherapie Ambulatoire".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Polyclinique de Blois; Chimiotherapie Ambulatoire,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Polyclinique de Blois; Chimiotherapie Ambulatoire, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".